These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 810385)

  • 1. Mutagenicity of alpha-acetoxy-dialkylnitrosamines: model compounds for an ultimate carcinogen.
    Okada M; Suzuki E; Anjo T; Mochizuki M
    Gan; 1975 Aug; 66(4):457-8. PubMed ID: 810385
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutagenic and DNA-damaging effects of N-alkyl-N-(alpha-acetoxyalkyl)nitrosamines, models for metabolically activated N,N-dialkylnitrosamines.
    Mochizuki M; Suzuki E; Anjo T; Wakabayashi Y; Okada M
    Gan; 1979 Oct; 70(5):663-70. PubMed ID: 118074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenic and DNA-damaging effects of N-(omega-acetoxyalkyl and omega-methoxycarbonylalkyl)-N-(alpha-acetoxyalkyl)nitrosamines, models for metabolically activated N,N-dialkylnitrosamines with an omega-functional group.
    Mochizuki M; Suzuki E; Anjo T; Wakabayashi Y; Okada M
    Gan; 1980 Feb; 71(1):124-30. PubMed ID: 6769736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mutagenicity of methylbenzylnitrosamine and its alpha-acetoxy derivatives.
    Tannenbaum SR; Kraft P; Baldwin J; Branz S
    Cancer Lett; 1977 May; 2(6):305-10. PubMed ID: 324607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High mutagenicity of N-(alpha-acyloxy)alkyl-N-alkylnitrosamines in S. typhimurium: model compounds for metabolically activated N,N-dialkylnitrosamines.
    Camus AM; Wiessler M; Malaveille C; Bartsch H
    Mutat Res; 1978 Feb; 49(2):187-94. PubMed ID: 342933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntheses of N-(omega-acetoxyalkyl and omega-carbomethoxyalkyl)-N-(alpha-acetoxy-alkyl)nitrosamines, model compounds for possible metabolically activated N,N-dialkylnitrosamines.
    Mochizuki M; Anjo T; Okada M
    Chem Pharm Bull (Tokyo); 1978 Dec; 26(12):3914-9. PubMed ID: 371842
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and mutagenicity of 4-(N-butylnitrosamino)-4-hydroxybutyric acid lactone, a possible activated metabolite of the proximate bladder carcinogen N-butyl-N-(3-carboxypropyl)nitrosamine.
    Mochizuki M; Irving CC; Anjo T; Wakabayashi Y; Suzuki E; Okada M
    Cancer Res; 1980 Jan; 40(1):162-5. PubMed ID: 6765916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity of five cyclic N-nitrosamines: assay with Salmonella typhimurium.
    Stoltz DR; Sen NP
    J Natl Cancer Inst; 1977 Feb; 58(2):393-4. PubMed ID: 319245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenicity of alpha-hydroxy N-nitrosamines in V79 Chinese hamster cells.
    Mochizuki M; Osabe M; Anjo T; Takeda K; Suzuki E; Okada M
    IARC Sci Publ; 1984; (57):715-9. PubMed ID: 6398304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium.
    Simmon VF
    J Natl Cancer Inst; 1979 Apr; 62(4):893-9. PubMed ID: 372657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenicity of aliphatic nitrosamines in Salmonella typhimurium.
    Rao TK; Young JA; Lijinsky W; Epler JL
    Mutat Res; 1979 Jan; 66(1):1-7. PubMed ID: 370582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of dietary protein deficiency on the ability of isolated hepatic microsomes to alter the mutagenicity of a primary and a secondary carcinogen.
    Czygan P; Greim H; Garro A; Schaffner F; Popper H
    Cancer Res; 1974 Jan; 34(1):119-23. PubMed ID: 4588542
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic alpha-hydroxylation of the tobacco-specific carcinogen, N'-nitrosonornicotine.
    Chen CB; Hecht SS; Hoffmann D
    Cancer Res; 1978 Nov; 38(11 Pt 1):3639-45. PubMed ID: 359127
    [No Abstract]   [Full Text] [Related]  

  • 14. Mutagenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine, a bladder carcinogen, and related compounds.
    Nagao M; Suzuki E; Yasuo K; Yahagi T; Seino Y
    Cancer Res; 1977 Feb; 37(2):399-407. PubMed ID: 318920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of some carcinogenic, mutagenic, and biochemical properties of S-vinylhomocysteine and ethionine.
    Leopold WR; Miller JA; Miller EC
    Cancer Res; 1982 Nov; 42(11):4364-74. PubMed ID: 6290034
    [No Abstract]   [Full Text] [Related]  

  • 16. The relationship between mutagenicity and carcinogenicity of some nitrosamines.
    Andrews AW; Thibault LH; Lijinsky W
    Mutat Res; 1978 Sep; 51(3):319-26. PubMed ID: 362177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenicity of alkyl-(omega-hydroxyalkyl) nitrosamines related to dibutylnitrosamine.
    Olajos EJ; Maverakis N; Cornish HH
    Mutat Res; 1978 Jan; 56(3):219-23. PubMed ID: 342939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the mutagenic action of carcinogens of the nitrosamine group].
    Pogodina ON
    Tsitologiia; 1966; 8(4):503-9. PubMed ID: 4962580
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutagenicity of chemical carcinogens.
    De Serres FJ
    Mutat Res; 1976 Nov; 41(1 spel. no):43-50. PubMed ID: 827703
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutagenicity of N-alkyl-N-(alpha-acetoxyalkyl) nitrosamines in V79 Chinese hamster cells in relation to alkylating activity.
    Huang GF; Mochizuki M; Anjo T; Okada M
    Gan; 1981 Aug; 72(4):531-8. PubMed ID: 7308664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.